Home
HelpTest Code AMLNG Myeloid Neoplasm NGS Panel for Acute Myeloid Leukemia (AML)
Additional Codes
| Epic Ordering Code | LAB3041864 |
| NBS code | LBC08394 |
| Service code | 1035095 |
Specimen Requirements
Submit the following:
| Preferred: |
|
Purple Top |
|
|
Processing Requirements
Specimen type: Whole Blood or Bone Marrow Aspirate
Volume: 3.0 mL (at least 1.0 mL for bone marrow aspirate)
Storage/transport requirements: Ambient or refrigerated
Specimen Stability
| Specimen Type | Whole Blood or Bone Marrow Aspirate |
| Ambient | 7 days |
| Refrigerate | 7 days |
Specimen Condition
| Frozen | Reject |
| Haemolysis | Reject |
Methodology
Next-generation sequencing
Days and Times Performed
TAT 3 - 4 weeks
Reference Interval
An interpretive report will be provided.
Testing Laboratory
National University Hospital
Genomics Diagnostic Laboratory, 67724384
Useful For
For acute myeloid leukemia (AML) with panel included:
ABL1, ANKRD26, ASXL1, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, DDX41, DNMT3A, ELANE, ETNK1, ETV6, EZH2, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, JAK2, KDM6A, KIT, KRAS, MLL, MPL, NF1, NPM1, NRAS, PDGFRA, PHF6, PPM1D, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, TET2, TP53, U2AF1, UBA1, UBTF, WT1, ZRSR2
The following additional test will also be performed: Fragment analysis for the FLT3 gene, enabling detection of both internal tandem duplications and mutations in the tyrosine kinase domain.
Update
Last updated 15/06/2026
Test Info
(a) This test was developed by NUH Laboratory Medicine.
(b) This laboratory test has undergone in-house evaluation with appropriate quality assurance and control measures in line with laboratory best practice and accreditation requirements.